259 related articles for article (PubMed ID: 35739562)
1. Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain.
Port H; Nielsen SH; Madsen SF; Bay-Jensen AC; Karsdal M; Seven S; Sørensen IJ; Morsel-Carlsen L; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Jun; 24(1):152. PubMed ID: 35739562
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix turnover biomarkers reflect pharmacodynamic effects and treatment response of adalimumab in patients with axial spondyloarthritis-results from two randomized controlled trials.
Port H; Holm Nielsen S; Frederiksen P; Madsen SF; Bay-Jensen AC; Sørensen IJ; Jensen B; Loft AG; Madsen OR; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2023 Aug; 25(1):157. PubMed ID: 37626399
[TBL] [Abstract][Full Text] [Related]
3. Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy.
Holm Nielsen S; Sun S; Bay-Jensen AC; Karsdal M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Thamsborg G; Madsen OR; Møller J; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Dec; 24(1):279. PubMed ID: 36564778
[TBL] [Abstract][Full Text] [Related]
4. Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.
Port H; Christiansen F; Nielsen SH; Frederiksen P; Bay-Jensen AC; Karsdal MA; Seven S; Sørensen IJ; Loft AG; Madsen OR; Ostergaard M; Pedersen SJ
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199849
[TBL] [Abstract][Full Text] [Related]
5. Novel Biomarker of Collagen Degradation Can Identify Patients Affected With Both Axial Spondyloarthritis and Crohn Disease.
Nielsen SH; Stahly A; Regner EH; Bay-Jensen AC; Karsdal MA; Kuhn KA
J Rheumatol; 2022 Dec; 49(12):1335-1340. PubMed ID: 35705233
[TBL] [Abstract][Full Text] [Related]
6. The utility of magnetic resonance imaging lesion combinations in the sacroiliac joints for diagnosing patients with axial spondyloarthritis. A prospective study of 204 participants including post-partum women, patients with disc herniation, cleaning staff, runners and healthy persons.
Seven S; Østergaard M; Morsel-Carlsen L; Sørensen IJ; Bonde B; Thamsborg G; Lykkegaard JJ; Hendricks O; Jørgensen NR; Pedersen SJ
Rheumatology (Oxford); 2020 Nov; 59(11):3237-3249. PubMed ID: 32240310
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging of Lesions in the Sacroiliac Joints for Differentiation of Patients With Axial Spondyloarthritis From Control Subjects With or Without Pelvic or Buttock Pain: A Prospective, Cross-Sectional Study of 204 Participants.
Seven S; Østergaard M; Morsel-Carlsen L; Sørensen IJ; Bonde B; Thamsborg G; Lykkegaard JJ; Hendricks O; Jørgensen NR; Pedersen SJ
Arthritis Rheumatol; 2019 Dec; 71(12):2034-2046. PubMed ID: 31309740
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: A cross-sectional study.
Juhl P; Bay-Jensen AC; Karsdal M; Siebuhr AS; Franchimont N; Chavez J
PLoS One; 2018; 13(12):e0207324. PubMed ID: 30507931
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
[TBL] [Abstract][Full Text] [Related]
10. Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.
Hušáková M; Bay-Jensen AC; Forejtová Š; Zegzulková K; Tomčík M; Gregová M; Bubová K; Hořínková J; Gatterová J; Pavelka K; Siebuhr AS
Sci Rep; 2019 Aug; 9(1):11218. PubMed ID: 31375691
[TBL] [Abstract][Full Text] [Related]
11. Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Schett G; Loza MJ; Palanichamy A; FitzGerald O; Ritchlin C; Bay-Jensen AC; Nielsen SH; Gao S; Hsia EC; Kollmeier AP; Xu XL; Baribaud F; Sweet K
Rheumatol Ther; 2022 Aug; 9(4):1017-1030. PubMed ID: 35352313
[TBL] [Abstract][Full Text] [Related]
12. Morphological characteristics of sacroiliac joint MRI lesions in axial spondyloarthritis and control subjects.
Seven S; Østergaard M; Morsel-Carlsen L; Sørensen IJ; Bonde B; Thamsborg G; Lykkegaard JJ; Pedersen SJ
Rheumatology (Oxford); 2022 Mar; 61(3):1005-1017. PubMed ID: 34097000
[TBL] [Abstract][Full Text] [Related]
13. Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis.
Groen SS; Nielsen SH; Bay-Jensen AC; Rasti M; Ganatra D; Oikonomopoulou K; Chandran V
Arthritis Res Ther; 2024 May; 26(1):107. PubMed ID: 38802975
[TBL] [Abstract][Full Text] [Related]
14. Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis.
Gudmann NS; Munk HL; Christensen AF; Ejstrup L; Sørensen GL; Loft AG; Karsdal MA; Bay-Jensen AC; He Y; Siebuhr AS; Junker P
Arthritis Res Ther; 2016 Jun; 18(1):141. PubMed ID: 27306080
[TBL] [Abstract][Full Text] [Related]
15. Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity.
Gudmann NS; Siebuhr AS; Christensen AF; Ejstrup L; Sørensen GL; Loft AG; Karsdal MA; Bay-Jensen AC; Munk HL; Junker P
Clin Exp Rheumatol; 2017; 35(4):653-659. PubMed ID: 28240584
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients.
Jensen C; Madsen DH; Hansen M; Schmidt H; Svane IM; Karsdal MA; Willumsen N
J Immunother Cancer; 2018 Dec; 6(1):152. PubMed ID: 30567561
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
Jenkins RG; Simpson JK; Saini G; Bentley JH; Russell AM; Braybrooke R; Molyneaux PL; McKeever TM; Wells AU; Flynn A; Hubbard RB; Leeming DJ; Marshall RP; Karsdal MA; Lukey PT; Maher TM
Lancet Respir Med; 2015 Jun; 3(6):462-72. PubMed ID: 25770676
[TBL] [Abstract][Full Text] [Related]
18. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N
Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598
[TBL] [Abstract][Full Text] [Related]
19. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
Kerbert AJC; Gupta S; Alabsawy E; Dobler I; Lønsmann I; Hall A; Nielsen SH; Nielsen MJ; Gronbaek H; Amoros À; Yeung D; Macnaughtan J; Mookerjee RP; Macdonald S; Andreola F; Moreau R; Arroyo V; Angeli P; Leeming DJ; Treem W; Karsdal MA; Jalan R
JHEP Rep; 2021 Dec; 3(6):100355. PubMed ID: 34805815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
